Kidney transplants in black recipients. HLA matching and other factors affecting long-term graft survival
- PMID: 8165704
Kidney transplants in black recipients. HLA matching and other factors affecting long-term graft survival
Abstract
Primary kidney transplants from living related and cadaveric donors to black recipients failed twice as rapidly as those to white recipients in data reported to the United Network for Organ Sharing Scientific Renal Transplant Registry between 1987 and 1991. The projected half-life for 132 HLA-identical sibling donor transplants in blacks was 15 years versus 29 years for 1,033 whites (P < 0.001). For recipients of cadaveric grafts, the half-lives were 5 years for blacks (n = 5,282) and 10 years for whites (n = 14,917). The 1-year graft survival rates and half-lives improved with HLA matching in both blacks and whites, but the 2-fold difference in long-term survival rates persisted even among recipients of well-matched grafts. With a zero HLA-A,B-mismatched donor, blacks had an 8-year half-life, compared with 17 years for whites (P < 0.001). The racial difference was most marked in young adults, with a 15-20% disparity at 3 years between blacks and whites aged 16-30. Pediatric and older black patients had 3-year graft survival rates similar to those of whites. Antilymphocyte globulin or OKT3 prophylaxis improved graft survival by 2% at 1 year and 5% at 2 years among blacks, but the half-life remained 5.6 years. In contrast to these findings in the United States, 63 blacks transplanted in Canada had the same short- and long-term graft survival as whites, suggesting an important long-term influence of the health care system and socioeconomic factors. In addition to improved access to health care and improved HLA typing of blacks, more black donors are needed to provide better matched transplants for blacks awaiting transplants.
Similar articles
-
The UNOS Scientific Renal Transplant Registry--2000.Clin Transpl. 2000:1-18. Clin Transpl. 2000. PMID: 11512303
-
The UNOS Scientific Renal Transplant Registry.Clin Transpl. 1996:1-14. Clin Transpl. 1996. PMID: 9286555
-
The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.Clin Transpl. 1997:1-14. Clin Transpl. 1997. PMID: 9919387
-
Calcineurin inhibitors in HLA-identical living related donor kidney transplantation.Nephrol Dial Transplant. 2014 Jan;29(1):209-18. doi: 10.1093/ndt/gft447. Nephrol Dial Transplant. 2014. PMID: 24414376 Free PMC article. Review.
-
Racial incidence of hemolytic uremic syndrome.Pediatr Nephrol. 1994 Oct;8(5):545-7. doi: 10.1007/BF00858122. Pediatr Nephrol. 1994. PMID: 7818999 Review.
Cited by
-
Disparities in kidney transplant outcomes: a review.Semin Nephrol. 2010 Jan;30(1):81-9. doi: 10.1016/j.semnephrol.2009.10.009. Semin Nephrol. 2010. PMID: 20116652 Free PMC article. Review.
-
The financial impact of immunosuppressant expenses on new kidney transplant recipients.Clin Transplant. 2008 Nov-Dec;22(6):738-48. doi: 10.1111/j.1399-0012.2008.00869.x. Epub 2008 Jul 31. Clin Transplant. 2008. PMID: 18673373 Free PMC article.
-
The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients.Front Pharmacol. 2020 Jul 31;11:1142. doi: 10.3389/fphar.2020.01142. eCollection 2020. Front Pharmacol. 2020. PMID: 32848756 Free PMC article. Review.
-
A systematic review of studies comparing health outcomes in Canada and the United States.Open Med. 2007 Apr 14;1(1):e27-36. Open Med. 2007. PMID: 20101287 Free PMC article.
-
The Impact of Recipient Demographics on Outcomes from Living Donor Kidneys: Systematic Review and Meta-Analysis.J Clin Med. 2021 Nov 26;10(23):5556. doi: 10.3390/jcm10235556. J Clin Med. 2021. PMID: 34884257 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials